Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 17 February, 2015

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 1728F
GlaxoSmithKline PLC
17 February 2015
 

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

 

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

 

The table below sets out changes in the interests of Directors and Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £15.4312 per Ordinary Share on 13 February 2015 to meet tax liabilities following the vesting of awards granted under the GlaxoSmithKline 2009 Performance Share Plan (PSP).

 


Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award

Sir Andrew Witty*

24,552

Mr S Dingemans*

12,605

Mr A Hussain

8,238

Mr D Redfern

4,723

Ms C Thomas

6,191

Mr P Thomson

3,149

Dr P Vallance

12,067

Ms E Walmsley

7,136

* Denotes an Executive Director

 

The table below sets out changes in the interests of PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a closing share price  of $46.21 per ADS on 11 February 2015 to establish the fair market value to meet tax liabilities following the vesting of awards granted under the PSP.

 


Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award

Mr W Louv

2,892

Mr D Troy

3,966

 

The Company, Directors and PDMRs were advised of these transactions on 17 February 2015.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

 

 

17 February 2015


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDDLFFELFXBBV

a d v e r t i s e m e n t